TMCnet News
Global Transplant Diagnostics Market Worth USD 753.9 Million by 2021 - Analysis, Technologies & Forecasts Report 2016-2021 - Key Vendors: Abbott Labs, Qiagen, Immucor - Research and MarketsResearch and Markets has announced the addition of the "Transplant Diagnostics Market by Technology, Products & Services, Application and by End User - Forecast to 2021" report to their offering. The global transplant diagnostics market is projected to reach USD 753.9 million by 2021 from USD 535.0 million in 2016, growing at a CAGR of 7.1%, during 2016 to 2021. Market growth can be attributed to factors such as rising number of solid organ, soft tissue, and stem cell transplantations; technological advancements; and increased funding, research grants, and public-private investments. However, high device costs associated with NGS and PCR (News - Alert)-based devices and limited medical reimbursements for organ donation and transplantation procedures restrain the growth of the transplant diagnostics market. Furthermore, the technological shift from serological assays to gene-based HLA profiling and improving healthcare infrastructure across developing countries provide various opportunities in the transplant diagnostics market.
Companies Mentioned:
Report Structure: 1 Introduction 2 Introduction 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Transplant Diagnostics Market, By Technology 8 Transplant Diagnostics Market, By Products & Services 9 Transplant Diagnostics Market, By Application 10 Transplant Diagnostics Market, By End User 11 Transplant Diagnostics Market, By Region 12 Competitive Landscape 13 Company Profiles 14 Appendix For more information visit http://www.researchandmarkets.com/research/9grg6r/transplant View source version on businesswire.com: http://www.businesswire.com/news/home/20160518006225/en/ |